Bernard Leduc - Concepedia

Author

Bernard Leduc

Also Known As

B E Leduc, B Leduc, B. E. Leduc, B. Leduc, Benjamin Leduc, Bernard E Leduc, Bernard E. Leduc, Bernard Leduc, J-P Guastalla, Jourd'Hui, Henri

161

Publications

4.8K

Citations

H-Index

103

Concepts

All Affiliations

Université de Montréal Inserm Quebec Rehabilitation Research Network Hôpital Notre-Dame Centre Hospitalier Universitaire de Tours

About

Bernard Leduc is an author at Université de Montréal specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	27	1.8K
2	Health Sciences	6	6	528
3	Public Health	3	3	130
4	Engineering	1	1	66
5	Applied Physiology	1	1	319

Bernard Leduc

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203 Jean‐Pierre Gérard, Thierry Conroy, Franck Bonnetain, Journal of Clinical Oncology	2006	1.7K
Electrical stimulation: Can it increase muscle strength and reverse osteopenia in spinal cord injured individuals? Marc Bélanger, Richard B. Stein, Garry D. Wheeler, Archives of Physical Medicine and Rehabilitation Motor ControlSpinal DisorderOrthopaedic SurgeryStimulation DeviceKinesiology	2000	319
Health-related quality of life after spinal cord injury Bernard Leduc, Yves Lepage Disability and Rehabilitation	2002	189
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial Xavier Pivot, Gilles Romieu, Marc Debled, The Lancet Breast OncologyOncologyEarly Breast CancerRandomised TrialBreast Cancer	2019	125
Preoperative (preop) radiotherapy (RT) ± 5 FU/folinic acid (FA) in T3–4 rectal cancers: results of the FFCD 9203 randomized trial J.P. Gérard, Frank Bonnetain, Thierry Conroy, Journal of Clinical Oncology Surgical OncologyCancer ManagementSurgeryGynecology OncologyT3–4 Rectal Cancers	2005	117
Increased reactive oxygen species formation in semen of patients with spinal cord injury Eve de Lamirande, Bernard Leduc, Akira Iwasaki, Fertility and Sterility Spinal Cord InjurySpinal TraumaSpinal InjuryNeurologyMedicine	1995	110
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group Sophie Camilleri‐Broët, Anne‐Claire Hardy‐Bessard, A. Le Tourneau, Annals of Oncology	2003	109
High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer Catherine Abrial, Frédérique Penault‐Llorca, R. Delva, Breast Cancer Research and Treatment Residual DiseaseSurgical OncologyBreast OncologyMedicinePathology	2005	105
The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction? G. Laval, J Girardier, Jean-Michel Lassaunière, Palliative Medicine Surgical OncologyGastroenterologyPathologySurgeryPharmacotherapy	2000	105
Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial Jean-Marc Ferrero, B. Weber, J.-F. Geay, Annals of Oncology Pegylated Liposomal DoxorubicinLate RelapseMedicinePharmacologyGynecology	2006	105

Page 1